Comparing two yeast infection treatments for women
Treatments studied
Part of Infections, Women’s health & pregnancy clinical trials.
This trial tests if a new combination vaginal suppository works better than the standard one for women with yeast infections. It aims to see if adding lactulose to clotrimazole helps clear the infection faster or more completely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 60 years old.
- You have a confirmed yeast infection (candidal vulvovaginitis).
- You are not pregnant, not breastfeeding, and will use reliable birth control during the study and for 30 days after.
- You have not used antibiotics or antifungal pills or creams in the last 2 weeks.
- You do not have bacterial vaginosis or other chronic conditions of the female organs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a probiotic product (good bacteria) can help treat vulvovaginal yeast infections alongside standard care. You'll use the probiotic for a set period and report how your symptoms improve.
This trial tests a new vaginal cooling device to treat yeast infections. It may help relieve symptoms like itching, burning, or irritation without medication.
This study tests a new oral medication called WXSH0102 for treating vaginal yeast infections (VVC). It aims to see if the drug is safe and effective for women with active symptoms.
This trial tests if taking a multi-strain probiotic daily can prevent repeat yeast infections in women who have had at least three infections in the past year.
This study tests occidiofungin, a new antifungal medication inserted into the vagina twice a week to prevent recurring yeast infections (vulvovaginal candidiasis). The goal is to see if this treatment can stop yeast infections from coming back.
This study tests a new antifungal medicine (oteseconazole) for women with a moderate to severe yeast infection. It aims to see if the drug works well and is safe.
Hear when a new Vulvovaginal Candidiasis (VVC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.